Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F Cowman

Showing results (191-200 of 232) with videos related to

Pageof 24
Sort By:
Antimicrobial Agents and Chemotherapy|January 14, 2026
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studiesSusan E Stanley, Russ P Carstens, Maria V Liberti, et al.
Cell Host & Microbe|July 5, 2016
Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of ErythrocytesJennifer C Volz, Alan Yap, Xavier Sisquella, et al.
Plos Biology|July 2, 2014
Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasitesBrad E Sleebs, Sash Lopaticki, Danushka S Marapana, et al.
Bioorganic Chemistry|August 28, 2021
Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activityBrodie L Bailey, William Nguyen, Anna Ngo, et al.
Plos One|October 3, 2012
The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malariaLinda Reiling, Jack S Richards, Freya J I Fowkes, et al.
The Journal of Clinical Investigation|August 2, 2012
Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunityJo-Anne Chan, Katherine B Howell, Linda Reiling, et al.
Cellular Microbiology|April 10, 2019
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytesJulie Healer, Wilson Wong, Jennifer K Thompson, et al.
ACS Infectious Diseases|December 2, 2025
Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in <i>Plasmodium falciparum</i> ParasitesWenyin Su, William Nguyen, Ghizal Siddiqui, et al.
Structure (London, England : 1993)|April 23, 2022
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N Hodder, Janni Christensen, Stephen Scally, et al.
Journal of Medicinal Chemistry|January 13, 2017
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo ActivityPaul R Gilson, Cyrus Tan, Kate E Jarman, et al.
Pageof 24

Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|January 14, 2026
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studiesSusan E Stanley, Russ P Carstens, Maria V Liberti, et al.
Cell Host & Microbe|July 5, 2016
Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of ErythrocytesJennifer C Volz, Alan Yap, Xavier Sisquella, et al.
Plos Biology|July 2, 2014
Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasitesBrad E Sleebs, Sash Lopaticki, Danushka S Marapana, et al.
Bioorganic Chemistry|August 28, 2021
Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activityBrodie L Bailey, William Nguyen, Anna Ngo, et al.
Plos One|October 3, 2012
The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malariaLinda Reiling, Jack S Richards, Freya J I Fowkes, et al.
The Journal of Clinical Investigation|August 2, 2012
Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunityJo-Anne Chan, Katherine B Howell, Linda Reiling, et al.
Cellular Microbiology|April 10, 2019
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytesJulie Healer, Wilson Wong, Jennifer K Thompson, et al.
ACS Infectious Diseases|December 2, 2025
Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in <i>Plasmodium falciparum</i> ParasitesWenyin Su, William Nguyen, Ghizal Siddiqui, et al.
Structure (London, England : 1993)|April 23, 2022
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N Hodder, Janni Christensen, Stephen Scally, et al.
Journal of Medicinal Chemistry|January 13, 2017
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo ActivityPaul R Gilson, Cyrus Tan, Kate E Jarman, et al.
Pageof 24